Hero

Celyad to Participate in Upcoming June 2019 Conferences

1

Celyad to Participate in Upcoming June 2019 Conferences

Celyad to Present Data at 24th Congress of the European Hematology Association

2

Celyad to Present Data at 24th Congress of the European Hematology Association

About Celyad

Making the Impossible Possible

Celyad is a clinical-stage biopharmaceutical that is developing next generation CAR-T NK cell-based immunotherapies for cancer treatment.

Latest News

Celyad to Participate in Upcoming June 2019 Conferences

Celyad to Participate in Upcoming June 2019 Conferences

Celyad to Present Data at 24th Congress of the European Hematology Association

Celyad to Present Data at 24th Congress of the European Hematology Association

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights

Discover all news

Carousel

Social Feed

Attending #EHA2019 ? Come and listen to Dr Peggy Sotiropoulou, R&D Director at @CelyadSA. #GeneTherapy #EHA24… https://t.co/VR7ObG4sKq

2 days ago

Attending #EHA2019 ? Come and listen to Dr Peggy Sotiropoulou, R&D Director at @CelyadSA. #GeneTherapy #EHA24… https://t.co/VR7ObG4sKq

Don't miss this interview of @filpetti , CEO of @CelyadSA ! #BIO2019 #CART #cancertherapy https://t.co/qHaxWhtGhb

3 days ago

Don't miss this interview of @filpetti , CEO of @CelyadSA ! #BIO2019 #CART #cancertherapy https://t.co/qHaxWhtGhb

@CelyadSA 's team is attending #EHA2019 in Amsterdam! We're excited to learn more about the advances in gene therap… https://t.co/sguoAWBBwy

3 days ago

@CelyadSA 's team is attending #EHA2019 in Amsterdam! We're excited to learn more about the advances in gene therap… https://t.co/sguoAWBBwy

@filpetti , Celyad’s CEO, sat down with DDNews to explain more about @CelyadSA ’s CAR-T technology and the roadbloc… https://t.co/kmNiHjDo22

4 days ago

@filpetti , Celyad’s CEO, sat down with DDNews to explain more about @CelyadSA ’s CAR-T technology and the roadbloc… https://t.co/kmNiHjDo22

Attending #EHA2019 ? Come and listen to Dr Peggy Sotiropoulou, R&D Director at @CelyadSA. #GeneTherapy #EHA24… https://t.co/VR7ObG4sKq

2 days ago

Attending #EHA2019 ? Come and listen to Dr Peggy Sotiropoulou, R&D Director at @CelyadSA. #GeneTherapy #EHA24… https://t.co/VR7ObG4sKq

Don't miss this interview of @filpetti , CEO of @CelyadSA ! #BIO2019 #CART #cancertherapy https://t.co/qHaxWhtGhb

3 days ago

Don't miss this interview of @filpetti , CEO of @CelyadSA ! #BIO2019 #CART #cancertherapy https://t.co/qHaxWhtGhb

@CelyadSA 's team is attending #EHA2019 in Amsterdam! We're excited to learn more about the advances in gene therap… https://t.co/sguoAWBBwy

3 days ago

@CelyadSA 's team is attending #EHA2019 in Amsterdam! We're excited to learn more about the advances in gene therap… https://t.co/sguoAWBBwy

@filpetti , Celyad’s CEO, sat down with DDNews to explain more about @CelyadSA ’s CAR-T technology and the roadbloc… https://t.co/kmNiHjDo22

4 days ago

@filpetti , Celyad’s CEO, sat down with DDNews to explain more about @CelyadSA ’s CAR-T technology and the roadbloc… https://t.co/kmNiHjDo22